
Narana Cables And Chemicals Pharmaceuticals Private Limited
Sells and buys land, incorporated in 1990, based in Mumbai.
Sells and buys land, incorporated in 1990, based in Mumbai.
Narana Cables And Chemicals Pharmaceuticals Private Limited (NCACPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 January 1990 and has a history of 35 years and four months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.40 M.
The company currently has active open charges totaling ₹2.50 Cr.
Gauri Mehta and Aniruddha Mehta serve as directors at the Company.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
U24232MH1990PTC178357
178357
Private Limited Indian Non-Government Company
08 Jan 1990
17 Aug 2024
31 Mar 2024
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gauri Mehta ![]() | Director | 08-Jan-1990 | Current |
Aniruddha Mehta ![]() | Director | 08-Jan-1990 | Current |
Narana Cables And Chemicals Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 24.59% decrease. The company also saw a substantial fall in profitability, with a 19.22% decrease in profit. The company's net worth moved up by a moderate rise of 0.09%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Narana Cables And Chemicals Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Gauri Mehta and Aniruddha Mehta are mutual person
Gauri Mehta and Aniruddha Mehta are mutual person
Gauri Mehta and Aniruddha Mehta are mutual person
Gauri Mehta is a mutual person
Gauri Mehta and Aniruddha Mehta are mutual person
Gauri Mehta and Aniruddha Mehta are mutual person
₹25.00 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
27 Nov 2001 | The Vysya Bank Ltd | ₹2.50 Cr | Open |
Unlock and access historical data on people associated with Narana Cables And Chemicals Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Narana Cables And Chemicals Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Narana Cables And Chemicals Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Narana Cables And Chemicals Pharmaceuticals Private Limited last Annual general meeting of members was held on 17 Aug 2024 as per latest MCA records.
Narana Cables And Chemicals Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
A charge with The Vysya Bank Ltd amounted to Rs. 25.00 M with Charge ID 90196409 was registered on 27 Nov 2001.
Gauri Aniruddha Mehta was appointed as a Director was appointed as a Director on 08 Jan 1990 & has been associated with this company since 35 years 4 months .
Aniruddha Bhanuprasad Mehta was appointed as a Director was appointed as a Director on 08 Jan 1990 & has been associated with this company since 35 years 4 months .
Narana Cables And Chemicals Pharmaceuticals Private Limited was registered on 08 Jan 1990 with Roc Mumbai & aged 35 years 4 months as per MCA records.
Narana Cables And Chemicals Pharmaceuticals Private Limited was incorporated on 08 Jan 1990.
The authorized share capital of Narana Cables And Chemicals Pharmaceuticals Private Limited is ₹ 1.50 M and paid-up capital is ₹ 1.40 M.
Currently 2 directors are associated with Narana Cables And Chemicals Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Narana Cables And Chemicals Pharmaceuticals Private Limited is Union Co-Op Insurance Building 3Rd Floor 23 Sir P M Road Fort, India, Mumbai, Maharashtra, 400001.
The corporate identification number (CIN) of Narana Cables And Chemicals Pharmaceuticals Private Limited is U24232MH1990PTC178357 and the company number is 178357 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Narana Cables And Chemicals Pharmaceuticals Private Limited has fallen by -24.59%.
The financial reports for the fiscal year 2022 indicates that The net worth of Narana Cables And Chemicals Pharmaceuticals Private Limited has experienced an upsurge of 0.09%.
As per the financial statements for fiscal Year 2022, The total open charges for Narana Cables And Chemicals Pharmaceuticals Private Limited amount to ₹ 2.50 Cr.
The most recent Balance Sheet for Narana Cables And Chemicals Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.